1. Home
  2. IMMP vs GDEV Comparison

IMMP vs GDEV Comparison

Compare IMMP & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • GDEV
  • Stock Information
  • Founded
  • IMMP 1987
  • GDEV 2009
  • Country
  • IMMP Australia
  • GDEV Cyprus
  • Employees
  • IMMP N/A
  • GDEV N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • GDEV EDP Services
  • Sector
  • IMMP Health Care
  • GDEV Technology
  • Exchange
  • IMMP Nasdaq
  • GDEV Nasdaq
  • Market Cap
  • IMMP 304.0M
  • GDEV 282.9M
  • IPO Year
  • IMMP N/A
  • GDEV N/A
  • Fundamental
  • Price
  • IMMP $1.92
  • GDEV $20.90
  • Analyst Decision
  • IMMP Buy
  • GDEV Buy
  • Analyst Count
  • IMMP 2
  • GDEV 2
  • Target Price
  • IMMP $8.50
  • GDEV $70.00
  • AVG Volume (30 Days)
  • IMMP 72.2K
  • GDEV 20.7K
  • Earning Date
  • IMMP 03-03-2025
  • GDEV 03-18-2025
  • Dividend Yield
  • IMMP N/A
  • GDEV N/A
  • EPS Growth
  • IMMP N/A
  • GDEV N/A
  • EPS
  • IMMP N/A
  • GDEV 2.04
  • Revenue
  • IMMP $2,563,302.00
  • GDEV $432,534,000.00
  • Revenue This Year
  • IMMP N/A
  • GDEV N/A
  • Revenue Next Year
  • IMMP $47.79
  • GDEV $9.01
  • P/E Ratio
  • IMMP N/A
  • GDEV $10.24
  • Revenue Growth
  • IMMP 9.59
  • GDEV N/A
  • 52 Week Low
  • IMMP $1.66
  • GDEV $14.26
  • 52 Week High
  • IMMP $3.34
  • GDEV $42.76
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 43.56
  • GDEV 67.29
  • Support Level
  • IMMP $1.94
  • GDEV $14.26
  • Resistance Level
  • IMMP $2.08
  • GDEV $15.80
  • Average True Range (ATR)
  • IMMP 0.08
  • GDEV 1.17
  • MACD
  • IMMP -0.00
  • GDEV 0.50
  • Stochastic Oscillator
  • IMMP 20.00
  • GDEV 63.03

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: